Correlation Between AptaBio Therapeutics and Shinsegae Engineering

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both AptaBio Therapeutics and Shinsegae Engineering at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AptaBio Therapeutics and Shinsegae Engineering into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AptaBio Therapeutics and Shinsegae Engineering Construction, you can compare the effects of market volatilities on AptaBio Therapeutics and Shinsegae Engineering and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AptaBio Therapeutics with a short position of Shinsegae Engineering. Check out your portfolio center. Please also check ongoing floating volatility patterns of AptaBio Therapeutics and Shinsegae Engineering.

Diversification Opportunities for AptaBio Therapeutics and Shinsegae Engineering

-0.52
  Correlation Coefficient

Excellent diversification

The 3 months correlation between AptaBio and Shinsegae is -0.52. Overlapping area represents the amount of risk that can be diversified away by holding AptaBio Therapeutics and Shinsegae Engineering Construc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Shinsegae Engineering and AptaBio Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AptaBio Therapeutics are associated (or correlated) with Shinsegae Engineering. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Shinsegae Engineering has no effect on the direction of AptaBio Therapeutics i.e., AptaBio Therapeutics and Shinsegae Engineering go up and down completely randomly.

Pair Corralation between AptaBio Therapeutics and Shinsegae Engineering

Assuming the 90 days trading horizon AptaBio Therapeutics is expected to under-perform the Shinsegae Engineering. In addition to that, AptaBio Therapeutics is 57.2 times more volatile than Shinsegae Engineering Construction. It trades about -0.28 of its total potential returns per unit of risk. Shinsegae Engineering Construction is currently generating about -0.38 per unit of volatility. If you would invest  1,810,000  in Shinsegae Engineering Construction on August 28, 2024 and sell it today you would lose (8,000) from holding Shinsegae Engineering Construction or give up 0.44% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

AptaBio Therapeutics  vs.  Shinsegae Engineering Construc

 Performance 
       Timeline  
AptaBio Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days AptaBio Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Shinsegae Engineering 

Risk-Adjusted Performance

19 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Shinsegae Engineering Construction are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Shinsegae Engineering sustained solid returns over the last few months and may actually be approaching a breakup point.

AptaBio Therapeutics and Shinsegae Engineering Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with AptaBio Therapeutics and Shinsegae Engineering

The main advantage of trading using opposite AptaBio Therapeutics and Shinsegae Engineering positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AptaBio Therapeutics position performs unexpectedly, Shinsegae Engineering can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Shinsegae Engineering will offset losses from the drop in Shinsegae Engineering's long position.
The idea behind AptaBio Therapeutics and Shinsegae Engineering Construction pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Other Complementary Tools

Global Correlations
Find global opportunities by holding instruments from different markets
CEOs Directory
Screen CEOs from public companies around the world
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets